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or rRNA molecules [15,16], with lower sensitivity to poor
sample handling. The expansion of this work into many other
infective contexts is now important, as obtaining more accu-
rate data on antibiotic impact could be of signiﬁcant potential
beneﬁt to patients.
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Abstract
Some of the members of the Mycobacterium avium–intracellulare
(MAI) complex are recognized as human pathogens in both immu-
nocompromised and immunocompetent patients. The current
molecular methods that are available for genotyping the MAI com-
plex members can be both expensive and technically demanding.
In this report, we describe for the ﬁrst time the application of a
real-time PCR and high-resolution melt approach to differentiate
between the complex members by targeting a member of the Pro-
Pro-Glu gene family, MACPPE24. To this end, reference strains of
the M. avium subspecies andMycobacterium intracellulare were used
to optimize the technique. Then, this real-time PCR–high-resolu-
tion melt approach was used to distinguish ten M. avium ssp.
hominissuis ﬁeld isolates from the M. intracellulare reference strain.
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The Mycobacterium avium complex (MAC) is made up of acid-
fast, slow-growing bacilli. Some of its members are strict
pathogens, whereas others are opportunistic or environmental
[1]. Although the deﬁnition of the MAC is controversial, from
a taxonomic point of view it includes the following M. avium
subspecies: M. avium ssp. avium, M. avium ssp. hominissuis,
M. avium ssp. paratuberculosis, M. avium ssp. silvaticum, and
Mycobacterium intracellulare [2]. In the case of M. avium ssp. silv-
aticum, because there are no full genome sequence data, its
classiﬁcation as a subspecies is based on the phenotypic char-
acteristics, with there being no evidence to date of genomic
divergence from its closest relative, M. avium ssp. avium [3–5].
From a clinical perspective, the complex has been deﬁned as
M. avium–intracellulare (MAI), including the M. avium subspe-
cies that cause disease in immunocompromised patients, cervi-
cal lymphadenitis in children, and chronic lung disease in
immunocompetent individuals [6]; and M. intracellulare, which
has been associated with pulmonary infections in both immu-
nocompromised and healthy individuals [2].
Currently, the methods used to discriminate between MAI
complex members in clinical samples are based on diagnostic
kits that are species-speciﬁc [7]—PCR sequencing of the
hsp65 gene [5], the dnaJ gene [8], the gyrB gene [9], the recA
gene [10], or the rpoB gene [11]—or by PCR directed at
IS1245 [12], or the mig gene, whose expression product is a
virulence factor present in M. avium subspecies but not in
M. intracellulare [13]. Real-time PCR and high-resolution melt
analysis (real-time PCR-HRM) is a novel technique that has
been used in mycobacteria as a rapid tool for the genotyping
of drug-resistant isolates of Mycobacterium tuberculosis
[14,15]. This technique was ﬁrst reported in 2002, and is
based on the analysis of the melting curves generated after
ampliﬁcation with a saturating dye such as EvaGreen [16].
Differences in the melting curves are dependent on the char-
acteristics of the DNA (sequence, GC content, etc.) and the
DNA extraction method, among other factors.
The polymorphic Pro-Pro-Glu (PPE) gene family encodes a
group of proteins speciﬁc to mycobacteria. In silico analysis of
one of these PPE genes, MACPPE24, revealed single-nucleo-
tide polymorphisms (SNPs) that were speciﬁc for each MAI
member [17]. This gene is present in one unique copy in
every MAI member, except for M. avium ssp. hominissuis, in
which two divergent copies are present in the genome
(Mav_2925c and Mav_2928c). This report describes the
development of a real-time PCR-HRM technique targeting
the MACPPE24 gene as a method for rapid discrimination
among MAI members.
In the current study, we included the sequenced reference
strains of M. avium ssp. hominissuis 104 (GenBank accesion
no. CP000479), M. intracellulare ATCC 13950 (GenBank
accesion no. ABIN00000000), M. avium ssp. avium
ATCC 25291 (GenBank accession no. NZ_ACFI00000000)
(kindly provided by M. Behr, McGill University, Canada), and
M. avium ssp. paratuberculosis K-10 (GenBank accession
no. AE016958). We also tested another ten M. avium ssp.
hominissuis ﬁeld isolates, recovered from swine (n = 8) and
cattle (n = 2) from nine different locations in Spain (culture
collection of VISAVET, Complutense University, Madrid,
Spain). All isolates and reference strains were tested in dupli-
cate. Reference strain culture and genomic DNA puriﬁcation
were performed as previously reported [18]. Initial DNA
extraction was performed by using a mechanical lysis step
using 0.1-mm zirconia beads (Biospec Products Inc., Bartles-
ville, OK, USA) in a MiniBeadbeater (Biospec Products Inc.)
at 6000 r.p.m. for 2 min. Culture and identiﬁcation of ﬁeld
M. avium ssp. hominissuis isolates were carried out as previ-
ously described [19], and the subsequent DNA puriﬁcation
was performed in the same manner as for the reference
strains. Forward (5¢-CGCAGTACATGGAGATGTGG-3¢),
reverse-A (5¢-CGGAGGTCTGTTTGAGCATC-3¢) and
reverse-B (5¢-CCGTGGTGCGTTTGAAGATC-3¢) primers
were designed to target 411 bp of the MACPPE24 gene
(bp 477–885), spanning SNPs that were MAI member-speciﬁc
(Fig. 1). The reverse-B primer was included to enable PCR
ampliﬁcation of M. intracellulare, which presented ﬁve mis-
matches in the binding region of the reverse-A primer. Reac-
tions were carried out in low 96-well clear Multiplate PCR
plates (Bio-Rad, Mississauga, Ontario, Canada), and sealed
with Microseal ‘B’ Film (Bio-Rad) in a ﬁnal volume of 20 lL
containing 2 lL of genomic DNA, 10 lL of the supermix
SsoFast EvaGreen (Bio-Rad), and 5 pmol of forward and
reverse-A and reverse-B primers. In a ﬁrst experiment,
genomic DNA from the reference strains alone was used as
a template. In a second experiment, samples of genomic
DNA from reference strains were spiked with M. avium ssp.
paratuberculosis K-10 DNA, leading to heteroduplex forma-
tion. This allowed further discrimination between M. avium
ssp. avium and M. avium ssp. hominissuis strains by increasing
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the differences in the melting curves, analogous to a method
previously introduced by Reed et al. [16]. PCR reactions
were performed in a CFX96 Real-Time PCR Detection
System (Bio-Rad) under the following conditions: initial dena-
turation at 98.0C for 2 min, 40 cycles at 98.0C for 5 s, and
annealing/extension at 55.0C for 10 s. Prior to high-resolu-
tion melt analysis, PCR products were heated to 95.0C for
1 min and then cooled down to 70.0C for 1 min. Then,
high-resolution melt analysis was carried out by ﬂuorescence
acquisition during a temperature increase from 70.0C to
99.0C, using increments of 0.2C with holding steps of 10 s.
The resulting melting proﬁles were analysed with Bio-Rad
Precision Melt Analysis software, using the normalization
regions between 89C and 90C, corresponding to the pre-
melting region and the post-melting region between 95C
and 96C. Of the M. avium ssp. hominissuis isolates included,
ﬁve were sequenced in both strands, forward and reverse,
to further validate the PCR-HRM data. The resulting melting
curves were also normalized to relative values of 100%
(corresponding to the pre-melting phase) to 0% (for the
post-melting phase) to eliminate the differences in back-
ground ﬂuorescence. First, we tested sequenced DNA, and
found that M. avium ssp. paratuberculosis and M. intracellulare
gave distinct proﬁles that were different from those of
FIG. 1. In silico sequence alignment with Clustal 2.0.11 multiple sequence alignment (European Bioinformatics Institute, Cambrige, UK) of the tar-
get region of the MACPPE24 gene in the reference strains of the Mycobacterium avium-intracellulare complex. Forward and reverse primers are
underlined. Mycobacterium avium ssp. hominissuis has two copies of this gene (Mav_2925c and Mav_2928c).
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M. avium ssp. hominissuis and M. avium ssp. avium, the latter
organisms being indistinguishable (Fig. 2a). Next, we tested
whether the addition of spiked M. avium ssp. paratuberculosis
DNA, to generate heteroduplexes, might help to provide
resolution between M. avium ssp. hominissuis and M. avium
ssp. avium. As shown in Fig. 2b, we found that complete dis-
crimination within MAI members was achieved with hetero-
duplex formation. Finally, to determine whether variability
within M. avium ssp. hominissuis might inﬂuence this assay, we
tested a number of ﬁeld isolates. As shown in Fig. 2c, the
same melting proﬁle as that of the reference strain was
obtained for all screened isolates. The application of the
PCR-HRM method described here represents a new trend in
the detection of SNPs that is able to discriminate among the
MAI members in <2 h. Among other molecular typing meth-
ods that are currently being used to differentiate between
MAI members, PCR-HRM is an inexpensive and simple geno-
typing method that produces rapid results [16]. This tech-
nique has been previously reported as a high-throughput
method, and has been successfully applied to other microor-
ganisms recovered from human clinical samples [20]. In this
study, addition of known genomic DNA to the samples was
used to enhance the differences observed in the melting pro-
ﬁles, in order to enable further discrimination between
M. avium ssp. hominissuis and M. avium ssp. avium. M. avium
ssp. avium is the causative agent of bird tuberculosis and
occasional infections in other animals. Accordingly, discrimi-
nation of this subspecies may not be necessary for human
diagnostics, thereby further simplifying the PCR-HRM proto-
col. The current assay could constitute a rapid way of geno-
typing the most common pathogens isolated from clinically
infected patients, M. avium ssp. hominissuis and M. intracellu-
lare. Currently, the tests most commonly used to differenti-
ate between MAI complex members are probe-based assays
directed at the 16S gene sequence, 16S–23S spacer region,
and 23S gene. However, owing to the associated cost and
technical demands, many diagnostic laboratories do not fur-
ther genotype the agents involved in the MAI complex-asso-
ciated diseases [7]. Therefore, routine genotyping by this
novel approach might provide insights into the involvement
of speciﬁc MAI complex members in diverse clinical pro-
cesses and diseases. Nevertheless, additional screening of a
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FIG. 2. (a) Graph showing the normalized melting proﬁles after PCR ampliﬁcation of the MACPPE24 gene in the different members of the Mycobac-
terium avium-intracellulare complex (MAC) without spiking of tested strains. Green: Mycobacterium intracellulare. Red: M. avium ssp. avium and M. avi-
um ssp. hominissuis. Blue: M. avium ssp. paratuberculosis. (b) Graph showing the differences in melting proﬁles after heteroduplex formation. The
colour scheme is the same as in (a), except that M. avium ssp. hominissuis is shown in orange. (c) Graph showing the differences in melting proﬁles
of all the M. avium ssp. hominissuis isolates and the reference strain tested (red) vs. M. intracellulare (green). Each isolate was tested in duplicate.
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collection of clinical isolates should be undertaken to test
the usefulness of this new method as well as the inclusion of
some of the recently accepted members of the complex,
such as Mycobacterium arosiense [21], Mycobacterium bouched-
urhonense, Mycobacterium marseillense, Mycobacterium timon-
ense [22], Mycobacterium chimaera [23], and Mycobacterium
colombiense [24].
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